Last updated: April 10, 2025
Sponsor: University Hospital, Basel, Switzerland
Overall Status: Completed
Phase
N/A
Condition
N/ATreatment
Telemedical care
Clinical Study ID
NCT05617560
2022-01440; am22Eckstein2
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Written informed consent as documented by signature from the patient
Planned hospital discharge
Intended follow-up care, that is manageable with telemedicine
Exclusion
Exclusion Criteria:
Significant mental or cognitive impairment
Unable or not willing to sign informed consent
Unable to understand German
No possibility of telecommunication or use of such (app or phone)
Study Design
Total Participants: 234
Treatment Group(s): 1
Primary Treatment: Telemedical care
Phase:
Study Start date:
October 26, 2022
Estimated Completion Date:
December 31, 2024
Study Description
Connect with a study center
University Hospital Basel, Division of Internal Medicine
Basel, 4031
SwitzerlandSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.